$6.50
0.081.25%
At close: Jun 12, 5:00 PM EST
$5.88
-0.62-9.54%
After Hours: Jun 9, 4:12 AM EST
Champions Oncology Inc Stock Guidance
CSBRNASDAQ
Champions Oncology (CSBR) last issued guidance on July 21, 2022 for fiscal year 2023. The company guided revenue in the range of $58.93M - $58.93M for the period.
Latest Guidance Date
Jul 21, 2022
Guidance Period
Full Year 2023
Revenue Guidance Range
$58.93M - $58.93M
Champions Oncology Guidance History
Review all historical guidance issued by Champions Oncology, including EPS and revenue forecasts across quarterly and annual periods.
Loading calendar...
FAQ
What is the most recent guidance for Champions Oncology (CSBR)?
The most recent guidance for Champions Oncology (CSBR) was reported on July 21, 2022 for the fiscal year 2023. Champions Oncology forecasted revenue between $58.93M and $58.93M for the period.
What revenue range did Champions Oncology (CSBR) guide for?
Champions Oncology (CSBR) guided revenue in the range of $58.93M to $58.93M for the fiscal year 2023.
When did Champions Oncology (CSBR) last issue guidance?
Champions Oncology (CSBR) last issued guidance on July 21, 2022 for the fiscal year 2023.
